两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-19-074375 Act: 34 Size: 456 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-19-074106 Act: 34 Size: 298 KB 网页链接
$Onconova医疗(ONTX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-19-074107 Act: 33 Size: 485 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, item 3.01 Accession Number: 0001104659-19-074102 Act: 34 Size: 16 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-19-071255 Act: 34 Size: 453 KB 网页链接
$Onconova医疗(ONTX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-19-071186 Act: 33 Size: 481 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-19-070818 Act: 34 Size: 44 KB 网页链接
$Onconova医疗(ONTX)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001104659-19-070579 Act: 34 Size: 128 KB 网页链接
$Onconova医疗(ONTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-19-025140 Act: 34 Size: 121 KB 网页链接
$Onconova医疗(ONTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-19-012105 Size: 8 KB 网页链接